1. Home
  2. RVSN vs INAB Comparison

RVSN vs INAB Comparison

Compare RVSN & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rail Vision Ltd.

RVSN

Rail Vision Ltd.

HOLD

Current Price

$0.36

Market Cap

20.9M

Sector

N/A

ML Signal

HOLD

Logo IN8bio Inc.

INAB

IN8bio Inc.

HOLD

Current Price

$2.59

Market Cap

22.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVSN
INAB
Founded
2016
2016
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
22.9M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
RVSN
INAB
Price
$0.36
$2.59
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$108.00
AVG Volume (30 Days)
3.3M
734.9K
Earning Date
02-03-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$776,000.00
N/A
Revenue This Year
$28.46
N/A
Revenue Next Year
$755.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$1.17
52 Week High
$1.58
$12.53

Technical Indicators

Market Signals
Indicator
RVSN
INAB
Relative Strength Index (RSI) 51.52 66.54
Support Level $0.31 $2.10
Resistance Level $0.41 $2.55
Average True Range (ATR) 0.04 0.27
MACD 0.00 0.01
Stochastic Oscillator 54.52 84.37

Price Performance

Historical Comparison
RVSN
INAB

About RVSN Rail Vision Ltd.

Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

Share on Social Networks: